Nutritional approach for patients with amyotrophic lateral sclerosis;Approche nutritionnelle des patients atteints de sclérose latérale amyotrophique

Revue Neurologique

Volumn 162, Issue HS2, 2006, Pages

  Piquet, M A ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

ALS; Gastrostomy; Nutrition

Indexed keywords

AMINO ACID; ANTIOXIDANT; CREATINE; SERUM ALBUMIN; VITAMIN D;

AMYOTROPHIC LATERAL SCLEROSIS; ARM MUSCLE; BODY COMPOSITION; BODY MASS; CATABOLISM; CONFERENCE PAPER; DISEASE COURSE; ENERGY EXPENDITURE; HUMAN; IMPEDANCE; MALNUTRITION; OSTEOPOROSIS; PREDICTION; PREVALENCE; PROTEIN INTAKE; SKINFOLD; SURVIVAL; TRICEPS BRACHII MUSCLE; WEIGHT REDUCTION;

AMYOTROPHIC LATERAL SCLEROSIS; DIETARY SUPPLEMENTS; GASTROSTOMY; HUMANS; NUTRITION ASSESSMENT; NUTRITIONAL REQUIREMENTS;

EID: 33749670143     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (64)

1. ANAES Haute Autorité de Santé. (1995). Nutrition péri-opératoire. Conférence de consensus. Soins Chir, 169 : 35-44.
2. ANAES Haute Autorité de Santé. (1998). Nutrition de l'agressé. Conférence de consensus. Ann Fr Anesth Reanim, 17 : 1274-1284.
3. ANAES Haute Autorité de Santé (2003). Évaluation diagnostique de la dénutrition protéino-énergétique des adultes hospitalisés. www.anaes.fr
4. ANC Apports nutritionnels conseillés. (2001). Apports nutritionnels conseillés pour la population française. AFSSA, CNERNA-CNRS. Coordonateur A Martin. Editions Tec & Doc.
5. APOSTOLSKI S, MARINKOVIC Z, NIKOLIC A, BLAGOJEVIC D, SPASIC MB, MICHELSON AM. (1998). Glutathione peroxidase in amyotrophic lateral sclerosis : the effects of selenium supplementation. J Environ Pathol Toxicol Oncol, 17: 325-329.
6. ASGE American Society for Gastrointestinal Endoscopy. (1998). Role of PEG/PEJ in enteral feeding. Gastrointest Endosc, 48: 699-701.
7. BAETEN C, HOEFNAGELS J. (1992). Feeding via nasogastric tube or percutaneous endoscopic gastrostomy. A comparison. Scand J Gastroenterol, 194: 95-98.
8. BEDLACK RS, MATHEW MC. (2005). Creatine for amyotrophic lateral sclerosis/motor neuron disease (protocole). Cochrane Database Syst Rev, 2: CD005225. www.thecochranelibrary.com
9. BLIN O, POUGET J, AUBRESPY G, GUELTON C, CREVAT A, SERRATRICE G. (1992). A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis. J Neurol, 239: 79-81.
10. BOITANO LJ, JORDAN T, BENDITT JO. (2001). Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS. Neurology, 56: 413-414.
11. CHIO A, CUCATTO A, TERRENI AA, SCHIFFER D. (1998). Reduced glutathione in amyotrophic lateral sclerosis : an open, crossover, randomized trial. Ital J Neurol, 19: 363-366.
12. CHIO A, FINOCCHIARO E, MEINERI P, BOTTACCHI E, SCHIFFER D. (1999). Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology 53: 1123-1125.
13. CHIO A, MORA G, LEONE M, MAZZINI L, COCITO D, GIORDANA MT, BOTTACCHI E, MUTANI R. Piemonte and Valle d'Aosta Register for ALS. (2002). Early symptom progression rate is related to ALS outcome : a prospective population-based study. Neurology, 59: 99-103.
14. CHIO A, GALLETTI R, FINOCCHIARO C, RIGHI D, RUFFINO MA, CALVO A, DI VITO N, GHIGLIONE P, TERRENI AA, MUTANI R. (2004). Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neurosurg Psychiatry, 75: 645-647.
15. DESNUELLE C, DIB M, GARREL C, FAVIER A. (2001) . A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord, 2: 9-18.
16. DESPORT JC, PREUX PM, TRUONG TC, VALLAT JM, SAUTEREAU D, COURATIER P. (1999). Nutritional status is a prognostic factor for survival in ALS patients. Neurology, 53: 1059-1063.
17. DESPORT JC, PREUX PM, TRUONG CT, COURAT L, VALLAT JM, COURATIER P. (2000). Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord, 1: 91-96.
18. DESPORT JC, PREUX PM, MAGY L, BOIRIE Y, VALLAT JM, BEAUFRERE B, COURATIER P. (2001). Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr, 74: 328-334.
19. DESPORT JC, PREUX PM, BOUTELOUP-DEMANGE C, CLAVELOU P, BEAUFRERE B, BONNET C, COURATIER PP. (2003). Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis. Am J Clin Nutr, 77: 1179-1185.
20. DRORY VE, GROSS D. (2002). No effect of creatine on respiratory distress in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 3: 43-46.
21. DUPUIS L, OUDART H, RENE F, GONZALEZ DE AGUILAR JL, LOEFFLER JP. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci, 101: 11159-11164.
22. ELLIS AC, ROSENFELD J. (2004). The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders. CNS Drugs, 18: 967-980.
23. FORBES RB, COLVILLE S, SWINGLER RJ, Scottish Motor Neurone Disease Research Group. (2004). Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease - a record linkage study from the Scottish Motor Neurone Disease Register. J Neurol, 251: 813-817.
24. GRAF M, ECKER D, HOROWSKI R, KRAMER B, RIEDERER P, GERLACH M et al. (2005). High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm, 112: 649-660.
25. GREGORY S, SIDEROWF A, GOLASZEWSKI AL, MCCLUSKEY L. (2002). Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival. Neurology, 58: 485-487.
26. GROENEVELD GJ, VELDINK JH, VAN DER TWEEL I, KALMIJN S, BEIJER C, DE VISSER M, WOKKE JH, FRANSSEN H, VAN DEN BERG LH. (2003). A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Ann Neurol, 53 : 437-445.
27. HEFFERNAN C, JENKINSON C, HOLMES T, FEDER G, KUPFER R, LEIGH PN, MCGOWAN S, RIO A, SIDHU P. (2004). Nutritional management in MND/ALS patients: an evidence based review. Amyotroph Lateral Scler Other Motor Neuron Disord, 5: 72-83.
28. HAVERKAMP LJ, APPEL V, APPEL SH. (1995). Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain, 118: 707-719.
29. ITALIAN ALS STUDY GROUP. (1993). Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? Neurology, 43: 2466-2470.
30. JOHKURA K, YAMADA H, KUROIWA Y. (2003). Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a word of caution. J Clin Neurosci, 10: 737.
31. KASARSKIS EJ, BERRYMAN S, VANDERLEEST JG, SCHNEIDER AR, MCCLAIN CJ. (1996). Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr, 63: 130-137.
32. KASARSKIS EJ, NEVILLE HE. (1996). Management of ALS : nutritional care. Neurology, 47: S118-S120.
33. KASARSKIS EJ, BERRYMAN S, ENGLISH T, NYLAND J, VANDERLEEST JG, SCHNEIDER A, BERGER R, MCCLAIN C. (1997). The use of upper extremity anthropometrics in the clinical assessment of patients with amyotrophic lateral sclerosis. Muscle Nerve, 20: 330-335.
34. KASARSKIS EJ, SCARLATA D, HILL R, FULLER C, STAMBLER N, CEDARBAUM JM. (1999). A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci, 169: 118-125.
35. LACOMBLEZ L, BENSIMON G, LEIGH PN, GUILLET P, MEININGER V. (1996). Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet, 347: 1425-1431.
36. LAWSON RM, DOSHI MK, INGOE LE, COLLIGAN JM, BARTON JR, COBDEN I. (2000). Compliance of orthopaedic patients with postoperative oral nutritional supplementation. Clin Nutr, 19: 171-175.
37. LECHTZIN N, WIENER CM, CLAWSON L, CHAUDHRY V, DIETTE GB. (2001). Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes. Neurology, 56: 753-757.
38. LEIGH PN, ABRAHAMS S, AL-CHALABI A, AMPONG MA, GOLDSTEIN LH, JOHNSON J, LYALL R, MOXHAM J, MUSTFA N, RIO A, SHAW C, WILLEY E, King's MND Care and Research Team. (2003). The management of motor neurone disease. J Neurol Neurosurg Psychiatry, 74 Suppl 4: iv32-iv47.
39. LOUWERSE ES, WEVERLING GJ, BOSSUYT PM, MEYJES FE, DE JONG JM. (1995). Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol, 52: 559-564.
40. MAZZINI L, CORRA T, ZACCALA M, MORA G, DEL PIANO M, GALANTE M. (1995). Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol, 242: 695-698.
41. MAZZINI L, BALZARINI C, COLOMBO R, MORA G, PASTORE I, DE AMBROGIO R, CALIGARI M. (2001). Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results. J Neurol Sci, 191: 139-144.
42. MATHUS-VLIEGEN LM, LOUWERSE LS, MERKUS MP, TYTGAT GN, VIANNEY DE JONG JM. (1994). Percutaneous endoscopic gastrostomy in patients with amyotrophic lateralsclerosis and impaired pulmonary function. Gastrointest Endosc, 40: 463-469.
43. MILLER RG, ROSENBERG JA, GELINAS DF, MITSUMOTO H, NEWMAN D, SUFIT R, BORASIO GD, BRADLEY WG, BROMBERG MB, BROOKS BR, KASARSKIS EJ, MUNSAT TL, OPPENHEIMER EA. (1999). Practice parameter: The care of the patient with amyotrophic lateral sclerosis (An evidence-based review). Muscle Nerve, 22: 1104-1118.
44. MITSUMOTO H, DAVIDSON M, MOORE D, GAD N, BRANDIS M, RINGEL S, ROSENFELD J, SHEFNER JM, STRONG MJ, SUFIT R, ANDERSON FA, ALS CARE Study Group. (2003). Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord, 4: 177-185.
45. NAU KL, BROMBERG MB, FORSHEW DA, KATCH VL. (1995). Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci, 129 Suppl: 47-49.
46. NAU KL, DICK AR, PETERS K, SCHLOERB PR. (1997).Relative validity of clinical techniques for measuring the body composition of persons with amyotrophic lateral sclerosis. J Neurol Sci, 152 Suppl 1: S36-S42.
47. ORRELL RW, LANE RJ, ROSS M. (2005). Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease. Cochrane Database Syst Rev, 1: CD002829.
48. PARTON M, MITSUMOTO H, LEIGH PN. (2003). Amino acids for amyotrophic lateral sclerosis / motor neuron disease. Cochrane Database Syst Rev, 4: CD003457.
49. PLAITAKIS A, SMITH J, MANDELI J, YAHR MD. (1988). Pilot trial of branched-chain aminoacids in amyotrophic lateral sclerosis. Lancet, 1: 1015-1018.
50. ROSENFELD J. (2001). A pilot trial of creatine in amyotrophic lateral sclerosis (abstract). Amyotroph Lateral Scler Other Motor Neuron Disord, 2 suppl 2: 20.
51. SATO Y, HONDA Y, ASOH T, KIKUYAMA M, OIZUMI K. (1997). Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis. Eur Neurol, 37: 225-229.
52. SCHOLS AM, SLANGEN J, VOLOVICS L, WOUTERS EF. (1998). Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 157: 1791-1797.
53. SHAW AS, AMPONG MA, RIO A, MCCULURE J, LEIGH PN, SIDHU PS. (2004). Entristar skin-level gastrostomy tube: primary placement with radiologic guidance in patients with amyotrophic lateral sclerosis. Radiology, 233: 392-399.
54. SHEFNER JM, CUDKOWICZ ME, SCHOENFELD D, CONRAD T, TAFT J, CHILTON M et al. (2004). A clinical trial of creatine in ALS. Neurology, 63: 1656-1661.
55. SHERMAN MS, PILLAI A, JACKSON A, HEIMAN-PATTERSON T. (2004). Standard equations are not accurate in assessing resting energy expenditure in patients with amyotrophic lateral sclerosis. JPEN J Parenter Enteral Nutr, 28: 442-446.
56. SHIMIZU T, HAYASHI H, TANABE H. (1991). Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Rinsho Shinkeigaku, 31: 255-259.
57. STAMBLER N, CHARATAN M, CEDARBAUM JM and ALS CNTF Treatment Study Group. (1998). Prognostic indicators of survival in ALS. Neurology, 50: 66-72.
58. STRONG MJ, ROWE A, RANKIN RN. (1999). Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis. J Neurol Sci, 169: 128-32.
59. TANDAN R, BROMBERG MB, FORSHEW D, FRIES TJ, BADGER GJ, CARPENTER J, KRUSINSKI PB, BETTS EF, ARCIERO K, NAU K. (1996). A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: Clinical, functional, and maximum isometric torque data. Neurology 47: 1220-1226.
60. TESTA D, CARACENI T, FETONI V. (1989). Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis. J Neurol, 236: 445-447.
61. THORNTON FJ, FOTHERINGHAM T, ALEXANDER M, HARDIMAN O, MCGRATH FP, LEE MJ. (2002). Amyotrophic lateral sclerosis: enteral nutrition provision-endoscopic or radiologic gastrostomy? Radiology, 224: 713-717.
62. THUONG M, LETEURTE S. (2003). Nutrition entérale en reanimation. Recommandations de la SRLF. Réanimation, 12 : 350-354.
63. WELTZ CR, MORRIS JB, MULLEN JL. (1992). Surgical jejunostomy in aspiration risk patients. Ann Surg, 215: 140-145.
64. WHO. (2003). Obésité : prévention et prise en charge de l'épidémie mondiale. Rapport technique 894. www.who.int/fr/